Open AccessSafety and Efficacy of ABT-874, a Fully Human Interleukin 12/23 Monoclonal Antibody, in the Treatment of Moderate to Severe Chronic Plaque Psoriasis
Author(s) -
Alexa B. Kimball,
Kenneth B. Gordon,
Richard Langley,
Alan Menter,
Elliot Chartash,
Joaquin Valdes
Publication year - 2008
Publication title -
archives of dermatology
Language(s) - English
Resource type - Journals
eISSN - 1538-3652
pISSN - 0003-987X
DOI - 10.1001/archdermatol.2007.63
Subject(s) - medicine , psoriasis , placebo , adverse effect , psoriasis area and severity index , gastroenterology , upper respiratory tract infection , randomized controlled trial , dermatology life quality index , surgery , dermatology , pathology , alternative medicine
To investigate the efficacy and safety of ABT-874, an interleukin 12/23 monoclonal antibody, in psoriasis.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom